Episode 33 - AstraZenica, GSK, Whitbread, Standard Chartered, IWG, Spotify & The Defensive Value Investor

from The Investor Way · host The Investor Way

In this episode we discuss AstraZenica, GlaxoSmithKline, Whitbread, Standard Chartered, IWG & Spotify. There is also a book review of The Defensive Value Investor by John Kingham at the end. $azn $gsk $wtb $stan $iwg $spot

Episode metadata supplied by the publisher feed · Published May 3, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 33 - AstraZenica, GSK, Whitbread, Standard Chartered, IWG, Spotify & The Defensive Value Investor

0:00 51:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Investor Way?

This episode is 51 minutes long.

When was this The Investor Way episode published?

This episode was published on May 3, 2021.

Can I download this The Investor Way episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!